Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Foresee Pharmaceuticals Selected for Late-Breaking Oral Presentation on its Aderamastat Phase 2 Study Results at the European Respiratory Society (ERS) International Congress 2023
2023-07-25 15:19
Mabwell Announces the NMPA Approval of Novel B7-H3 ADC (7MW3711) for IND
2023-07-22 00:00
SunHo Announces First Patient Dosed in Phase I/II Clinical Trial of a Potential First-in-class Immunocytokine IBB0979
2023-07-21 22:51
GC Biopharma's "GC FLU" obtains vaccine approval in Egypt: First-ever approval of the company's quadrivalent flu vaccine on the African continent
2023-07-21 16:47
Jacobio Pharma to Present Data of Glecirasib in Combination with JAB-3312 at the 2023 ESMO Conference
2023-07-21 10:19
US FDA Grants Orphan Drug Designation of SN Bioscience's Nano Anti-Cancer Drug 'SNB-101' for Small Cell Lung Cancer
2023-07-21 08:15
BioCity announces the first patient dosed with its first-in-class CDH3-targeting ADC BC3195 in a Phase 1 Trial
2023-07-20 10:41
Biotheus Announces Strategic Research Collaboration and Worldwide License Agreement with BioNTech
2023-07-20 09:01
Yikaida CAR-T Cell Therapy Approved as a Second-line Therapy for New Indication
2023-07-19 10:42
Mabwell Announces the NMPA Approval of Novel Trop-2 ADC (9MW2921) for IND
2023-07-19 00:00
Samsung Biologics releases 2023 ESG Report, reaffirming its commitment to net-zero progress and corporate social responsibility
2023-07-18 19:00
Viva Biotech's Portfolio Company DTx Pharma Reached the Acquisition Agreement with Novartis
2023-07-18 15:00
SK Biopharmaceuticals Makes Big Bets to be 'Big Biotech'
2023-07-18 09:00
Qilian International Holding Group Ltd Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
2023-07-17 22:30
BIORCHESTRA Wins Grand Prize in 2023 Merck Advance Biotech Grant Program
2023-07-17 21:28
GeneQuantum and InxMed have reached a technology licensing collaboration, providing strong support for innovative ADC drug research and development
2023-07-17 17:00
Harbour BioMed Announces 2023 Interim Results Positive Profit Alert with the Enhancement of Value Driven by Innovation
2023-07-13 18:11
Medicilon Appoints Dr. Liu Jian as President of Drug Discovery Division
2023-07-12 18:46
Doer Biologics Announces License Agreement with BioNTech
2023-07-11 11:49
Race executes global license agreement with City of Hope to access FTO IP
2023-07-10 19:30
1
43
44
45
46
47
165